Ansell Limited
ANN.AXHealthcareASXMedical Instruments & Supplies
Scan Results
Daily timeframePart of the healthcare sector, Ansell Limited (ANN.AX) is listed under Medical Instruments & Supplies. At a $3.88B market cap, Ansell Limited ranks as a mid-cap company within healthcare. It operates through two segments: Healthcare and Industrial.
Market Cap
$3.88B
Beta
0.55
P/E (TTM)
21.04
P/E (Fwd)
12.72
EPS (TTM)
$1.30
EPS (Fwd)
$2.15
ROE
7.0%
ROA
5.7%
Cash
$250.7M
Total Debt
$833.7M
Free CF
$114.5M
52W Change
-14.2%
Annual Financials
Cash vs Debt
The company holds $250.7M in cash, though total debt stands at $833.7M. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Annual free cash flow of $114.5M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. Return on equity stands at 7.0%, which is modest for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. An ROA of 5.7% suggests reasonable efficiency in deploying the company's asset base. Revenue has been relatively flat, moving from $1.95B (2022) to $2.00B (2025).
ANN.AX's low beta indicates it tends to be less volatile than the broader market, which may suit investors seeking more stable price behavior. No single metric tells the full story. Reviewing ANN.AX's risk profile alongside its fundamentals and technical indicators provides a more complete picture.